Food-borne Illness
Withdrawal periods for flunixin-N-methyl glucamine in bovine milk established
Published in Medical Letter on the CDC and FDA, September 21st, 2003
According to a study from the United States, "The objective of this study was to establish a withdrawal period for flunixin in milk by quantifying 5-hydroxyflunixin, the marker residue, in bovine milk as a function of time, following intravenous treatment of lactating dairy cows with flunixin-N-methyl glucamine (Banamine or Finadyne)."
"Lactating dairy cows were dosed on three consecutive days at 2.2 mg of flunixin free acid/kg of body weight/day," stated Maureen A. Ngoh and colleagues at the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Resistance
Structure-based phenotyping predicts HIV-1 protease inhibitor resistance - HIV/AIDS Diagnosis
Whole-blood agglutination assay allows on-site detection of HIV infection - Anthrax
Pathology and pathogenesis of inhalational anthrax reviewed - Antimicrobial Resistance
Program controls vancomycin-resistant Enterococcus among inpatients - Poliovirus
Endemic type 2 vaccine-derived poliovirus found in Egypt from 1983 to 1993 - Vaccinology
Standards for adult immunization practices revised - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
